Feng L., Cheah I.K., Ng M.M., Li J., Chan S.M., Lim S.L., Mahendran R., Kua E.H., Halliwell B. The Association between Mushroom Consumption and Mild Cognitive Impairment: A Community-Based Cross-Sectional Study in Singapore. Journal of Alzheimer's Disease. 2019;68(1):197–203.
Rationale
The Halliwell group had already shown lower plasma ergothioneine in MCI; this study asked whether dietary mushroom intake itself tracks with MCI prevalence.
Methods
663 Singaporeans ≥60 from the Diet and Healthy Aging study; food-frequency intake (golden, oyster, shiitake, button, canned, dried; portion ≈150 g); MCI by clinical criteria; logistic regression with demographic, vascular and lifestyle adjustments.
Results
2 portions/week vs <1: OR=0.43 (95% CI 0.23–0.78; p=0.006) — roughly half the odds of MCI, robust to the full adjustment set.
Conclusions
Cross-sectional data consistent with a protective dietary role of mushrooms in early neurodegeneration; prospective and interventional confirmation needed.
Worth noting
Cross-sectional — mushrooms and MCI measured at one time point, so causality can run backwards (people in early decline cook less) or via overall diet quality. A "portion" of 150 g makes the protected category 300+ g/week — ordinary in Singapore, substantial elsewhere. Most valuable as one link in this group's coherent research line: diet → plasma ergothioneine → pilot intervention (NCT03641404); standalone proof it is not.